Mary Bird Perkins Cancer Center - Metairie — Metairie, Louisiana

Mary Bird Perkins Cancer Center - Metairie is a clinical research site located in Metairie, Louisiana, United States 70002.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Mary Bird Perkins Cancer Center - Metairie has participated in 15 clinical trials with 15 currently active.

Therapeutic areas: Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma, Muscle Invasive Ureter Urothelial Carcinoma.

Sponsors: National Cancer Institute (NCI), NRG Oncology, Alliance for Clinical Trials in Oncology.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mary Bird Perkins Cancer Center - Metairie?

Mary Bird Perkins Cancer Center - Metairie has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mary Bird Perkins Cancer Center - Metairie conducted?

Mary Bird Perkins Cancer Center - Metairie has 15 clinical trials on record, with 15 currently active. Their work covers Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma, Muscle Invasive Ureter Urothelial Carcinoma.

Is Mary Bird Perkins Cancer Center - Metairie accredited by Crixeo Health?

Yes — Mary Bird Perkins Cancer Center - Metairie holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Mary Bird Perkins Cancer Center - Metairie?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.